Pyxis Oncology, Inc.
Developing next-gen ADC and Immuno-Oncology therapeutics for difficult-to-treat cancers.
PYXS | NDAQ
Overview
Corporate Details
- ISIN(s):
- US7473241013
- LEI:
- Country:
- United States of America
- Address:
- 321 HARRISON AVENUE, 2118 BOSTON
- Website:
- https://pyxisoncology.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pyxis Oncology, Inc. is a clinical-stage biopharmaceutical company focused on developing an arsenal of next-generation therapeutics for difficult-to-treat cancers. The company has assembled a differentiated portfolio of clinical assets centered on two key platforms: Antibody-Drug Conjugates (ADCs) and Immuno-Oncology (IO). Its ADC technology platform is designed to deliver potent cancer-killing agents directly to tumor cells for safer and more effective treatments. The company's IO approaches, including monoclonal antibody (mAb) immunotherapies, aim to mobilize the patient's immune system to attack cancer. Pyxis Oncology develops its product candidates as both monotherapies and in combination with other therapies to improve outcomes for cancer patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Pyxis Oncology, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pyxis Oncology, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pyxis Oncology, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
